You just read:

Ampio Injects First Patients in 2nd Phase III, Pivotal Clinical Trial for Ampion™(The STEP Study) for Its FDA Biological License Application (BLA).

News provided by

Ampio Pharmaceuticals, Inc.

Jan 13, 2014, 08:00 EST